IFNAR2 and COVID-19: These data collectively indicate similar correlations as those for the overall hospitalized patients: COVID-19 patients with loss of taste or smell, carrying the minor variants of IFNAR2, LZTFL1 and RAVER1 (and probably also MUC5B and UGT2A1), are more likely to have hospitalization-requiring COVID-19 disease than the general population.